Impact of polymorphisms in genes involved in autoimmune disease on inhibitor development in Chinese patients with haemophilia A

Thrombosis and Haemostasis

Volumn 107, Issue 1, 2012, Pages 30-36

  Lu, Yeling ^a   Ding, Qiulan ^a   Dai, Jing ^a   Wang, Hongli ^a   Wang, Xuefeng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Cytokine; Haemophilia A; Inhibitors; Polymorphisms

Indexed keywords

BLOOD CLOTTING FACTOR 8 INHIBITOR; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 16; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ARTICLE; AUTOIMMUNE DISEASE; CHINESE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 GENE; GAMMA INTERFERON GENE; GENE; GENE FREQUENCY; GENE LOCUS; GENOTYPE; HAPLOTYPE; HEMOPHILIA A; HETEROZYGOTE; HUMAN; INTERLEUKIN 10 GENE; INTERLEUKIN 13 GENE; INTERLEUKIN 16 GENE; INTERLEUKIN 4 GENE; MAJOR CLINICAL STUDY; MICROSATELLITE MARKER; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR NECROSIS FACTOR ALPHA GENE;

ALLELES; AUTOIMMUNE DISEASES; CHINA; COHORT STUDIES; CTLA-4 ANTIGEN; CYTOKINES; FACTOR VIII; GENOTYPE; HAPLOTYPES; HEMOPHILIA A; HETEROZYGOTE; HUMANS; INTERLEUKIN-10; MICROSATELLITE REPEATS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84855314714     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH11-06-0425     Document Type: Article

References (19)

1. Pavlova A, Delev D, Lacroix-Desmazes S, et al. Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-a and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A. J Thromb Haemost 2009; 7: 2006-2015
2. Oldenburg J, Schroder J, Brackmann HH, et al. Environmental and genetic factors influencing inhibitor development. Semin Hematol 2004; 41 (Suppl 1): 82-88
3. Gouw SC, van den Berg HM, Le Cessie S, van der Bom JG. Treatment characteristics and the risk of inhibitor development: a multicenter cohort study among previously untreated patients with severe hemophilia. J Thromb Haemost 2007; 5: 1383-1390
4. Astermark J, Oldenburg J, Carlson J, et al. Polymorphisms in the TNFA gene and the risk of inhibitor development in patients with hemophilia A. Blood 2006; 108: 3739-3745
5. Astermark J, Oldenburg J, Escobar M, et al.; Malmo International Brother Study study group. The Malmo International Brother Study (MIBS). Genetic defects and inhibitor development in siblings with severe hemophilia A. Haematologica 2005; 90: 924-931
6. Lacroix-Desmazes S, Navarrete AM, Andre S, et al. Dynamics of factor VIII interactions determine its immunologic fate in hemophilia A. Blood 2008; 15: 240-249
7. Astermark J, Oldenburg J, Pavlova A, et al. Polymorphisms in the IL10 but not in the IL1beta and IL4 genes are associated with inhibitor development in patients with hemophilia A. Blood 2006; 107: 3167-3172
8. Astermark J, Wang X, Oldenburg J, et al. Polymorphisms in the CTLA-4 gene and inhibitor development in patients with severe hemophilia A. J Thromb Haemost 2007; 5: 263-265
9. Hiromatsu Y, Fukutani T, Ichimura M, et al. Interleukin-13 Gene Polymorphisms Confer the Susceptibility of Japanese Populations to Graves' Disease. J Clin Endocrinol Metab 2005; 90: 296-301
10. Rekha PL, Ishaq M, Valluri V. A Differential Association of Interferon-r High-Producing Allele T and Low-Producing Allele A (+874 A/T) with Hashimoto's Thyroiditis and Graves' Disease. Scand J Immunol 2006; 64: 438-443
11. Nakayama EE, Wasi C, Ajisawa A, et al. A new polymorphism in the promoter region of the human interleukin-16 (IL-16) gene. Genes Immun 2000; 1:293-294
12. Yee LJ, Tang J, Gibson AW, et al. Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection. Hepatology 2001; 33: 708-712
13. Rees LE, Wood NA, Gillespie KM, et al. The interleukin-10-1082G/A polymorphism: allele frequency in different populations and functional significance. Cell Mol Life Sci 2002; 59: 560-569
14. Lacroix-Desmazes S, Navarrete AM, Andre S, et al. Dynamics of factor VIII interactions determine its immunologic fate in hemophilia A. Blood. 2008; 15: 240-249
15. Eskdale J, Gallagher G, Verweij CL, et al. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci USA 1998; 95: 9465-9470
16. Eskdale J, Keijsers V, Huizinga T, et al. Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus. Genes Immun 1999; 1: 151-155
17. Djukanovic R. The role of co-stimulation in airway inflammation. Clin Exp Allergy 2000; 30: S46-50
18. Hausl C, Ahmad RU, Schwarz HP, et al, Reipert BM. Preventing restimulation of memory B cells in hemophilia A: a potential new strategy for the treatment of antibodydependent immune disorders. Blood 2004; 104: 115-122
19. Pavlova A, DiazLacava A, Zeitler H et al. Increased frequency of the CTLA4 + 49 A/G polymorphism in patients with acquired haemophilia A compared to healthy controls. Haemophilia 2008; 14: 355-360.